# Genetic Newborn Screening for Cystinosis and Spinal Muscular Atrophy

> **NCT06027385** · NA · COMPLETED · sponsor: **Cystinose Stiftung** · enrollment: 300000 (actual)

## Conditions studied

- Cystinosis
- Cystinosis, Nephropathic
- Spinal Muscular Atrophy

## Interventions

- **DIAGNOSTIC_TEST:** molecular-based screening

## Key facts

- **NCT ID:** NCT06027385
- **Lead sponsor:** Cystinose Stiftung
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 300000 (ACTUAL)
- **Last updated:** 2023-09-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06027385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06027385, "Genetic Newborn Screening for Cystinosis and Spinal Muscular Atrophy". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06027385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*